|
⚲
|
| Keyboard |
| Anderman Todd
✚
|
|
|---|---|
| CIK # | 0002039533 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002039533] | |
| 4 | [0002039533] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ocular Therapeutix Inc | |
| Anderman Todd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ocular Therapeutix Inc OCUL
Common Stock
|
2026-01-02 | Grant | 64,900 | $0.00 | |
|
Ocular Therapeutix Inc OCUL
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 197,650 | $0.00 | |
|
Ocular Therapeutix Inc OCUL
Common Stock
|
2025-10-08 | Sell | 11,132 | $12.34 | 137,369 |
|
Ocular Therapeutix Inc OCUL
Common Stock
|
2024-10-07 | Grant | 98,700 | $0.00 | |
|
Ocular Therapeutix Inc OCUL
Stock Option (Right to Buy) · derivative
|
2024-10-07 | Grant | 296,500 | $0.00 |